Esophageal adenocarcinoma (EAC) represents one of the most formidable challenges in modern oncology, recognized as the sixth leading cause of ...
![PD-L1 targeting molecular imaging in head and neck carcinoma: A head-to-head comparison of [18F]AlF-NOTA-PCP2 PET and [18F]FDG PET/CT.](https://bioengineer.org/wp-content/uploads/2025/06/SNMMI-Image-of-the-Year-Novel-Immuno-PET-Tracer-Outperforms-FDG-350x250.jpeg)
A groundbreaking advancement in molecular imaging has recently emerged from the realm of nuclear medicine, promising to redefine how clinicians ...
In a groundbreaking advancement poised to revolutionize oncological treatment, scientists at the Spanish National Cancer Research Centre (CNIO) have unveiled ...
In the relentless battle against cancer, understanding how tumors evolve to resist treatment remains one of the most formidable challenges ...
In a groundbreaking study published in BMC Cancer, researchers unveil the pivotal role of a circular RNA, circSLC22A3, in suppressing ...
A groundbreaking pan-cancer study published in BMC Cancer unveils the intricate landscape of homologous recombination deficiency (HRD) and homologous recombination ...
Reston, VA (April 18, 2025)—In a series of breakthrough developments, The Journal of Nuclear Medicine (JNM) has unveiled pioneering research ...
In a groundbreaking development that challenges established conventions in neuro-oncology, researchers at St. Jude Children’s Research Hospital have unveiled compelling ...
